CHLS Seminar: High Prices of Medicines and The Regulation of Intellectual Property in Europe

Abstract The recent arrival of Direct-Acting Antivirals (DAAs) against Hepatitis C in Europe has opened up an unprecedented debate about the price of medicines. It has highlighted a much greater systemic problem which goes beyond the cost of DAAs. It… Continue Reading